首页> 外文OA文献 >Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin’s lymphoma

【2h】

Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin’s lymphoma

机译：单独或与利妥昔单抗联合使用剂量调整后的环磷酰胺，阿霉素，长春新碱和泼尼松龙化疗后自体外周血干细胞动员治疗高危非霍奇金淋巴瘤

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin’s lymphoma [J] . Yuankai Shi, Ping Zhou, Xiaohong Han, Chinese journal of cancer . 2015,第3期

机译：单独或与利妥昔单抗联合使用剂量调整后的环磷酰胺，阿霉素，长春新碱和泼尼松龙化疗后自体外周血干细胞动员可治疗高危非霍奇金淋巴瘤
2. Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin’s lymphoma [J] . Yuankai Shi, Ping Zhou, Xiaohong Han, Cancer Communications . 2015,第3期

机译：单独或与利妥昔单抗联合使用剂量调整后的环磷酰胺，阿霉素，长春新碱和泼尼松龙化疗后自体外周血干细胞动员可治疗高危非霍奇金淋巴瘤
3. Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma: 7-year follow-up results. [J] . Tobinai K, Ogura M, Itoh K, Cancer science. . 2010,第12期

机译：Ⅱ期利妥昔单抗联合CHOP（环磷酰胺，阿霉素，长春新碱和泼尼松龙）联合化疗治疗未经治疗的惰性B细胞非霍奇金淋巴瘤的随机II期研究：7年的随访结果。
4. AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION FOR THE TREATMENT OF CANINE LYMPHOMA [C] . Steven E. Suter Canadian Veterinary Medical Association Convention . 2009

机译：用于治疗犬淋巴瘤的自体外周血干细胞移植
5. Systems pharmacology modeling of rituximab and doxorubicin in non-Hodgkin's lymphoma. [D] . Zhao, Xiaochen. 2016

机译：非霍奇金淋巴瘤中利妥昔单抗和阿霉素的系统药理模型。
6. Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide doxorubicin vincristine and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin’s lymphoma [O] . Yuankai Shi, Ping Zhou, Xiaohong Han, 2015

机译：单独或与利妥昔单抗联合使用剂量调整后的环磷酰胺阿霉素长春新碱和泼尼松龙化疗后自体外周血干细胞动员治疗高危非霍奇金淋巴瘤
7. Erratum: Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma [O] . 2011

机译：错误的：在非常贫困的未经治疗的未处理弥漫性大型B细胞非霍格金淋巴瘤中，用Rituximab患者的剂量调整的流管环磷酰胺，多柔比蛋白，长春新碱和泼尼松化疗的活动和安全性

Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin’s lymphoma

著录项

引文网络

相似文献

相关主题

期刊订阅